HUNTSVILLE — Huntsville’s healthŌme, a genomics-based precision health management company, has received the 2024 Global Innovation Award for “advancing personalized, genomics-driven healthcare.”
The company and its subsidiary, Kailos Genetics, are based at the HudsonAlpha Institute for Biotechnology in Huntsville’s Cummings Research Park.
In partnership with reinsurer Hannover Re, healthŌme received the award in the Life-Health-Retirement category. Presented by the International Insurance Society, Insurance Thought Leadership, and Lloyd’s, the award celebrates organizations driving transformative solutions to critical insurance and risk management challenges.
“Receiving the 2024 Global Innovation Award is a testament to healthŌme’s dedication to advancing personalized, genomics-driven healthcare,” said healthŌme CEO Darren Rowe. “The support from Hannover Re, our reinsurer, and Chubb, our exclusive distribution partner in the worksite, has been vital in providing solutions that prioritize a proactive approach to health-first insurance-based programs that reshape how the industry serves members.”
According to a news release, the award acknowledges the notable impact of healthŌme’s precision health management program. With support from Hannover Re, healthŌme integrated genomics-based services into critical illness and life insurance, delivering an innovative solution to the personal insurance market.
“We’re thrilled to receive this prestigious award, in collaboration with our partner healthŌme, that recognizes our commitment to advancing medical care for the treatment of cancer patients,” said Steve Najjar, executive vice president, head of Health Solutions and general counsel at Hannover Life Reassurance Company of America. “This partnership allows us to leverage genomic-based technologies and life insurance solutions to enhance patient care and support individuals in living longer, healthier lives.”
In partnership with Chubb, healthŌme’s innovative services are distributed through Chubb workplace benefits as Cancer Advocate Plus. healthŌme provides employees access to proactive, DNA-based precision health insights, a personalized medication optimization plan, and tailored cancer management support.
In 2025, the product will also be available for individuals to purchase outside the workplace as Kadance Precision Health Management Program.
Don’t miss out! Subscribe to our email newsletter to have all our smart stories delivered to your inbox.
